Lyell Immunopharma (LYEL) Selling, General & Administrative (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Lyell Immunopharma | 379.11 Mn | 379.11 Mn | - | 9.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.56 Mn |
| Dec 31, 2025 | 10.62 Mn |
| Sep 30, 2025 | 10.69 Mn |
| Jun 30, 2025 | 9.79 Mn |
| Mar 31, 2025 | 14.05 Mn |
| Dec 31, 2024 | 14.52 Mn |
| Sep 30, 2024 | 11.77 Mn |
| Jun 30, 2024 | 12.26 Mn |
| Mar 31, 2024 | 13.49 Mn |
| Dec 31, 2023 | 13.17 Mn |
| Sep 30, 2023 | 15.51 Mn |
| Jun 30, 2023 | 19.03 Mn |
| Mar 31, 2023 | 19.28 Mn |
| Dec 31, 2022 | 26.35 Mn |
| Sep 30, 2022 | 26.08 Mn |
| Jun 30, 2022 | 30.45 Mn |
| Mar 31, 2022 | 34.42 Mn |
| Dec 31, 2021 | 31.87 Mn |
| Sep 30, 2021 | 21.24 Mn |
| Jun 30, 2021 | 19.11 Mn |
| Mar 31, 2021 | 16.83 Mn |
| Dec 31, 2020 | 14.87 Mn |
| Sep 30, 2020 | 13.57 Mn |
| Jun 30, 2020 | 9.56 Mn |